Loading clinical trials...

Hemodynamic Parameters in People With Atherosclerotic Vascular Disease Referred to a Secondary Prevention and Cardiovascular Rehabilitation Program | Clinical Trials | Clareo Health

ACTIVE_NOT_RECRUITINGNA

Hemodynamic Parameters in People With Atherosclerotic Vascular Disease Referred to a Secondary Prevention and Cardiovascular Rehabilitation Program

Evolution of Hemodynamic Parameters in People With Atherosclerotic Vascular Disease Referred to a Secondary Prevention and Cardiovascular Rehabilitation (PREV) Program: a Prospective Cohort Study.

NCT06701032•Laval University

View on ClinicalTrials.gov

Summary

The main purpose of this study is to evaluate the hemodynamic changes in the forefoot of patients with coronary, cerebrovascular or peripheral atherosclerotic disease referred a 12-week cardiovascular rehabilitation program (PREV program). Also, this study will describe the characteristics of patients admitted to the PREV program and their evolutions in terms of favorable, unfavorable outcomes and complications and up to one year after completion of the program.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Any individual aged 18 years and older who has been diagnosed with peripheral artery disease, coronary artery disease, angina, ischemic heart failure, transient ischemic attack or ischemic stroke (non-cardioembolic, non-hemorrhagic);
•Have been admitted to the PREV program;

Exclusion Criteria

•Being not able to give written informed consent;

Locations (1)

CLSC de Lévis - Programme PREV du CISSS de Chaudière-Appalaches

Lévis, Quebec, Canada

Key Dates

Start Date

November 25, 2024

Primary Completion Date

August 29, 2025

Completion Date

March 1, 2026

Last Updated

August 22, 2025

Enrollment

ESTIMATED participants

Conditions

Peripheral Artery Disease (PAD)Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))Cerebrovascular Atherosclerosis

Interventions

Cardiovascular rehabilitation program

OTHER

Safety and Effectiveness of the Peripheral Balloon-Expandable Covered Stent System for Iliac Artery Stenosis/Occlusion. (SELECT)

NCT06605209

Peripheral Artery Disease (PAD)

View study

RECRUITING

Angioplasty With Shockwave IVL Catheter System in Femoropopliteal Lesions

NCT06713850

Peripheral Artery Disease (PAD)Chronic Limb Threatening Ischemia

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 22, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Hemodynamic Parameters in People With Atherosclerotic Vascular Disease Referred to a Secondary Prevention and Cardiovascular Rehabilitation Program

Inclusion Criteria

Exclusion Criteria

Safety and Effectiveness of the Peripheral Balloon-Expandable Covered Stent System for Iliac Artery Stenosis/Occlusion. (SELECT)

Angioplasty With Shockwave IVL Catheter System in Femoropopliteal Lesions

Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease

Effect of Diabetic Foot Exercises on Peripheral Vascular Status in Type 2 Diabetes Mellitus Patients

The REVEALPLAQUE Study: A pRospEctiVe, multicEnter Study to AnaLyze PLAQUE Using CCTA

Development of a Novel Risk Prediction Tool for Emergency Department Patients Symptoms of Coronary Artery Disease